Biography of Matthew Blischak
Last update: March 5, 2024Career
Matthew was Vice President, Intellectual and Property Counsel at Roivant Sciences, and Vice President and General Counsel, Global Specialty IP Litigation at Teva Pharmaceuticals. Matthew Blischak joined Finch Therapeutics in 2023.
Matthew Blischak is currently Chief Executive Officer and Director at Finch Therapeutics - View - Finch Therapeutics org chart
Create your alert
to follow the career of Matthew Blischak.
Education
Matthew Blischak has a Master of Science in Biotechnology from Johns Hopkins University and a Juris Doctor from American University, Washington College of Law.
They have also studied at Johns Hopkins University :
Find more alumni from Johns Hopkins University
They have also studied at American University, Washington College of Law :
Find more alumni from American University, Washington College of Law
More about Matthew Blischak
Selected links
Do you need to know more about Matthew Blischak? More results.
Participate
Social media
- Matthew Blischak on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Matthew Blischak
The colleagues of Matthew Blischak
Company Colleagues
- At Finch Therapeutics, Matthew Blischak has 9 colleagues including Susan Graf (Chairman of the Board), Jeff Smisek (Director)…
Industry Colleagues
- In the Biotechnology industry, Matthew Blischak has 30,319 colleagues in 2,286 companies located in 40 countries. 14,308 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Matthew Blischak.
